- Inogen press release ( NASDAQ: INGN ): Q4 Non-GAAP EPS of -$0.57 beats by $0.08 .
- Revenue of $88.09M (+15.3% Y/Y) misses by $1.61M .
For further details see:
Inogen Non-GAAP EPS of -$0.57 beats by $0.08, revenue of $88.09M misses by $1.61MFor further details see:
Inogen Non-GAAP EPS of -$0.57 beats by $0.08, revenue of $88.09M misses by $1.61MMarket Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
2024-03-27 17:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced management will participate in the 23 rd Annual Needham Virtual Healthcare Conference. Kevin Smith, President and Chief Executive Offi...
Inogen, Inc . (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that, effective March 4, 2024, the Compensation Committee of Inogen’s Board of Directors approved awards of restricted stock units as ...